BACKGROUND: Amotivation, or decisional anhedonia, is a prominent and disabling feature of depression. However, this aspect of depression remains understudied, and no prior work has applied objective laboratory tests of motivation in both unipolar and bipolar depression. METHODS: We assessed motivation deficits using a Progressive Ratio Task (PRT) that indexes willingness to exert effort for monetary reward. The PRT was administered to 96 adults ages 18-60 including 25 participants with a current episode of unipolar depression, 28 with bipolar disorder (current episode depressed), and 43 controls without any Axis I psychiatric disorders. RESULTS: Depressed participants exhibited significantly lower motivation than control participants as objectively defined by progressive ratio breakpoints. Both the unipolar and bipolar groups were lower than controls but did not differ from each other. LIMITATIONS: Medication use differed across groups, and we did not have a separate control task to measure psychomotor activity; however neither medication effects or psychomotor slowing are likely to explain our findings. CONCLUSIONS: Our study fills an important gap in the literature by providing evidence that diminished effort on the PRT is present across depressed patients who experience either unipolar or bipolar depression. This adds to growing evidence for shared mechanisms of reward and motivation dysfunction, and highlights the importance of improving the assessment and treatment of motivation deficits across the mood disorders spectrum.
BACKGROUND: Amotivation, or decisional anhedonia, is a prominent and disabling feature of depression. However, this aspect of depression remains understudied, and no prior work has applied objective laboratory tests of motivation in both unipolar and bipolar depression. METHODS: We assessed motivation deficits using a Progressive Ratio Task (PRT) that indexes willingness to exert effort for monetary reward. The PRT was administered to 96 adults ages 18-60 including 25 participants with a current episode of unipolar depression, 28 with bipolar disorder (current episode depressed), and 43 controls without any Axis I psychiatric disorders. RESULTS:Depressedparticipants exhibited significantly lower motivation than control participants as objectively defined by progressive ratio breakpoints. Both the unipolar and bipolar groups were lower than controls but did not differ from each other. LIMITATIONS: Medication use differed across groups, and we did not have a separate control task to measure psychomotor activity; however neither medication effects or psychomotor slowing are likely to explain our findings. CONCLUSIONS: Our study fills an important gap in the literature by providing evidence that diminished effort on the PRT is present across depressedpatients who experience either unipolar or bipolar depression. This adds to growing evidence for shared mechanisms of reward and motivation dysfunction, and highlights the importance of improving the assessment and treatment of motivation deficits across the mood disorders spectrum.
Authors: Joseph R Calabrese; Maurizio Fava; George Garibaldi; Heinz Grunze; Andrew D Krystal; Thomas Laughren; Wayne Macfadden; Robert Marin; Andrew A Nierenberg; Mauricio Tohen Journal: J Affect Disord Date: 2014-07-10 Impact factor: 4.839
Authors: Diego A Pizzagalli; Dan Iosifescu; Lindsay A Hallett; Kyle G Ratner; Maurizio Fava Journal: J Psychiatr Res Date: 2008-04-22 Impact factor: 4.791
Authors: Henry W Chase; Robin Nusslock; Jorge Rc Almeida; Erika E Forbes; Edmund J LaBarbara; Mary L Phillips Journal: Bipolar Disord Date: 2013-10-21 Impact factor: 6.744
Authors: Isabella Pacchiarotti; David J Bond; Ross J Baldessarini; Willem A Nolen; Heinz Grunze; Rasmus W Licht; Robert M Post; Michael Berk; Guy M Goodwin; Gary S Sachs; Leonardo Tondo; Robert L Findling; Eric A Youngstrom; Mauricio Tohen; Juan Undurraga; Ana González-Pinto; Joseph F Goldberg; Ayşegül Yildiz; Lori L Altshuler; Joseph R Calabrese; Philip B Mitchell; Michael E Thase; Athanasios Koukopoulos; Francesc Colom; Mark A Frye; Gin S Malhi; Konstantinos N Fountoulakis; Gustavo Vázquez; Roy H Perlis; Terence A Ketter; Frederick Cassidy; Hagop Akiskal; Jean-Michel Azorin; Marc Valentí; Diego Hidalgo Mazzei; Beny Lafer; Tadafumi Kato; Lorenzo Mazzarini; Anabel Martínez-Aran; Gordon Parker; Daniel Souery; Ayşegül Ozerdem; Susan L McElroy; Paolo Girardi; Michael Bauer; Lakshmi N Yatham; Carlos A Zarate; Andrew A Nierenberg; Boris Birmaher; Shigenobu Kanba; Rif S El-Mallakh; Alessandro Serretti; Zoltan Rihmer; Allan H Young; Georgios D Kotzalidis; Glenda M MacQueen; Charles L Bowden; S Nassir Ghaemi; Carlos Lopez-Jaramillo; Janusz Rybakowski; Kyooseob Ha; Giulio Perugi; Siegfried Kasper; Jay D Amsterdam; Robert M Hirschfeld; Flávio Kapczinski; Eduard Vieta Journal: Am J Psychiatry Date: 2013-11 Impact factor: 18.112
Authors: Diego A Pizzagalli; Elena Goetz; Michael Ostacher; Dan V Iosifescu; Roy H Perlis Journal: Biol Psychiatry Date: 2008-02-01 Impact factor: 13.382
Authors: Claudia Hägele; Florian Schlagenhauf; Michael Rapp; Philipp Sterzer; Anne Beck; Felix Bermpohl; Meline Stoy; Andreas Ströhle; Hans-Ulrich Wittchen; Raymond J Dolan; Andreas Heinz Journal: Psychopharmacology (Berl) Date: 2014-06-29 Impact factor: 4.530
Authors: Brandon A Newmyer; Ciarra M Whindleton; Peter M Klein; Mark P Beenhakker; Marieke K Jones; Michael M Scott Journal: JCI Insight Date: 2019-04-02
Authors: Anup Sharma; Daniel H Wolf; Rastko Ciric; Joseph W Kable; Tyler M Moore; Simon N Vandekar; Natalie Katchmar; Aylin Daldal; Kosha Ruparel; Christos Davatzikos; Mark A Elliott; Monica E Calkins; Russell T Shinohara; Danielle S Bassett; Theodore D Satterthwaite Journal: Am J Psychiatry Date: 2017-01-31 Impact factor: 18.112
Authors: Ivan Grahek; Amitai Shenhav; Sebastian Musslick; Ruth M Krebs; Ernst H W Koster Journal: Neurosci Biobehav Rev Date: 2019-05-27 Impact factor: 8.989